185 related articles for article (PubMed ID: 24337348)
21. Imaging-guided radiofrequency ablation of solid renal tumors.
Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma After Radiofrequency Ablation.
Zhang F; Chang X; Liu T; Wang W; Zhao X; Ji C; Yang R; Guo H
J Endourol; 2016 Jan; 30(1):37-42. PubMed ID: 26222920
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
24. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
25. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.
Sung HH; Park BK; Kim CK; Choi HY; Lee HM
Int J Hyperthermia; 2012; 28(3):227-34. PubMed ID: 22515344
[TBL] [Abstract][Full Text] [Related]
26. [Radio-frequency ablation of T1a renal cell carcinoma].
Fujito A; Kawauchi A; Yoneda K; Ukimura O; Miki T
Hinyokika Kiyo; 2005 Aug; 51(8):523-5. PubMed ID: 16164267
[TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
[TBL] [Abstract][Full Text] [Related]
29. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
30. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
Park S; Strup SE; Saboorian H; Cadeddu JA
Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma.
Iguchi T; Hiraki T; Tomita K; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Kanazawa S
Diagn Interv Imaging; 2016 Nov; 97(11):1159-1164. PubMed ID: 27256108
[TBL] [Abstract][Full Text] [Related]
32. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.
Varkarakis IM; Allaf ME; Inagaki T; Bhayani SB; Chan DY; Su LM; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2005 Aug; 174(2):456-60; discussion 460. PubMed ID: 16006864
[TBL] [Abstract][Full Text] [Related]
38. Early experience with percutaneous radiofrequency ablation of small solid renal masses.
Roy-Choudhury SH; Cast JE; Cooksey G; Puri S; Breen DJ
AJR Am J Roentgenol; 2003 Apr; 180(4):1055-61. PubMed ID: 12646454
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
